Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
about
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)Current Management of Alcoholic Hepatitis and Future TherapiesNext Steps Toward Eradication of Hepatitis C in the Era of Direct Acting AntiviralsHow important is donor age in liver transplantation?Management of hepatitis c genotype 4 in the liver transplant settingKASL clinical practice guidelines: management of hepatitis CAdvances in hepatitis C therapy: What is the current state - what come's next?Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizonLiver transplantation for viral hepatitis in 2015New approaches in the treatment of hepatitis CEra of direct acting antivirals in chronic hepatitis C: Who will benefit?Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug ResistanceManagement of Hepatitis C Post-liver Transplantation: a Comprehensive ReviewImpact of new treatment options for hepatitis C virus infection in liver transplantationInterferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipientsHepatitis C cirrhosis: New perspectives for diagnosis and treatmentTreatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos inHepatitis C: New challenges in liver transplantationChanging the face of hepatitis C management - the design and development of sofosbuvirHepatitis C virus-HIV-coinfected patients and liver transplantationTherapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver CirrhosisConcise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infectionOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisFuture of liver disease in the era of direct acting antivirals for the treatment of hepatitis CHepatitis C virus infection.APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Regression of hepatocellular carcinoma after treatment of hepatitis C: a case report.Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study.Hepatitis C Virus and Liver Transplantation.Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis.Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?Predictive factors associated with hepatitis C antiviral therapy response.Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant CandidatesSerum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin.Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis
P2860
Q26740319-CAB04C3F-A0DF-47A7-B70C-E7F4AD24BDECQ26746544-093F1164-2E61-4E7B-907D-5AF1357063AFQ26747561-A5481B9C-0FE0-4BE2-B4A7-08A70275AEB0Q26747570-F7012973-825C-4D77-9801-19D8E40E290CQ26749326-30F1F5EB-FB26-4253-BB92-2DBA235DF839Q26752471-C52D3C84-26F9-4C7B-B331-79E69400B8A9Q26770036-3B31EABD-4E21-48D4-8803-AEC33296121CQ26773201-4870E24B-0DAB-4EA7-BBB4-84A97AC207F6Q26773224-B93E4C8C-2700-43D0-9910-C4BD47568266Q26773271-2177F767-2443-4048-BE2A-C2740345D3C4Q26777506-5422B080-92A9-4F88-AE57-9C5748CACB8BQ26781331-3C41CD20-207E-4E2C-8939-8ADCDB0F81ACQ26781741-EC6A4DB4-1059-4FE8-AF13-C113B876C1F2Q26782017-93710E23-F557-4FF1-A177-D092D0154F77Q26795595-D9535900-BB2C-41EA-96E8-F56F161E3C8FQ26799924-4A653B24-6F11-4957-BCCC-90DBA7EE6E06Q26820811-E239FC54-E70D-4CCA-9044-4B1B2D90BA8EQ26999368-88D129F1-4FB6-4862-961F-2157EF6C1BF0Q27011203-BE7E6AD1-4FD4-485D-A862-92752609F71DQ27011255-0EDAEF85-2D9C-479B-855C-7D3A4B704F0FQ28070260-37A8DFA1-340F-4134-939B-41818FE058EFQ28075544-051E3BC8-0A44-4FCA-AAB1-92F3CA6010BCQ28075646-29E5DAF4-F974-4D3A-9398-31BF09C3367AQ30235178-42CA7A47-932D-4B6E-9332-5209914084B1Q30235491-F5E54727-B8B9-4229-88F6-A0719D8CE6B0Q30250088-0C4DF094-8A5D-4634-9706-376B42EF95DAQ30250096-57FBEFB9-BD38-4780-BD9A-56CA4FD5D76FQ30279258-9719D5C2-5AEF-44B1-8EEB-2F94A3F98314Q30355190-03E3D920-28F3-41EE-B49F-80944B4F968CQ30375305-6FDB7C69-37DE-4244-B88C-28DD313E547BQ33427048-FCD9B5C8-F2FC-4B29-A53C-4644ECC413B8Q33435950-38DFF4B2-2857-4EB8-9011-323E22ACC9DEQ33717116-5752444F-0A3E-4662-BBEA-AB72B1E97556Q34522481-8070AA2C-3828-44A4-94B8-4A96885D682FQ35228316-0EDC2974-E636-42B6-9BA5-6BA12D87E714Q35790393-85D8BA2E-E228-4009-9CC2-AE28E351CF54Q35790397-E10ABD07-564B-4ED9-B0FF-36354BD5E0EAQ35901512-86DACAFC-A63E-428B-921F-C6003C7A52C8Q35975174-2DB9BDB7-B2CF-4333-9A6E-FDA8E8F87B1FQ35995534-BB83CFBB-AAF4-4CE0-91B7-D28BF675EE6B
P2860
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Sofosbuvir and ribavirin preve ...... antation: an open-label study.
@en
type
label
Sofosbuvir and ribavirin preve ...... antation: an open-label study.
@en
prefLabel
Sofosbuvir and ribavirin preve ...... antation: an open-label study.
@en
P2093
P50
P1433
P1476
Sofosbuvir and ribavirin preve ...... antation: an open-label study.
@en
P2093
Alex Befeler
Dilip Moonka
Edward Gane
Eugene Schiff
Evguenia Svarovskaia
Fredric Gordon
G Mani Subramanian
Gregory Everson
Jacqueline O'Leary
Jill Denning
P304
100-107.e1
P356
10.1053/J.GASTRO.2014.09.023
P407
P577
2014-09-28T00:00:00Z